Back to search

University of Crete (UOC)

Ιστοειδική έκφραση ανοσορυθμιστικών μεσολαβητών σε πνευμονικό ιστό ασθενών με Χ.Α.Π. και συσχέτιση με γενετική αστάθεια στο Μικροδορυφορικό DNA

Abstract

dc:description

Pulmonary surfactant is a complex mixture of lipids and proteins that constitutes the mobile liquid phase covering the large surface area of the alveolar epithelium. It maintains minimal surface tension within the lungs in order to avoid lung collapse during respiration. Recent studies have shown that components of Pulmonary surfactant also function in the pulmonary host defence as immune mediators. Pulmonary surfactant is composed of phospholipids, neutral lipids and surfactant proteins (SP). The SPs are divided into the hydrophobic SP-B and SP-C and the hydrophilic SP-A and SP-D. SP-B and SP-C lower the alveolar surface tension, while SP-A and SP-D are primarily concerned with host-defense functions, acting as immune mediators. Although pulmonary surfactant has the potential to contribute to the pathogenesis of COPD, very little work has been done in this field. On the other hand, in a recent study of our laboratory, detected Microsatellite DNA Instability (MSI) on G29802 (10q22) marker next to SP-A locus gene only in COPD patients. Taking into account all the evidence supporting that surfactant, especially the immunomodulatory protein SP-A, may be involved in the pathogenesis of COPD, we investigate: 1) the expression levels (by western blot and immunostaining) of SP-A in lung tissue of COPD patients in comparison to non-COPD smokers with equivalent smoking 5 history, and control non-smokers and 2) the relationship between the expression levels of SP-A and the degree of airway obstruction. To the best of our knowledge this is the first study of SP-A expression in lung tissue of COPD patients, non-COPD smokers and control non- smokers. Western blots on lung tissue specimens from 60 male subjects (32 COPD patients, 18 non-COPD smokers and 10 control non-smokers) for SP-A and the housekeeping actin, have been carried out. In addition, by immunostaining the expression pattern of the SP-A was determined in formalinfixed, paraffin-embedded lung tissue sections from the same subjects. Western blots for SP-A showed decreased, but not statistically significant, levels in COPD patients (0.6±0.7) in comparison with non-COPD smokers (2.4±0.9), (p=0.12). SP-A levels in control non-smokers were significantly higher (4.8±0.05), (p>0.05). The immunostaining showed increased overall number of pneumocytes type II cells in COPD patients but decreased ratio of SP-A positive pneumocytes type II to total pneumocyte type II cells, compared to control smokers (p=0.001). This ratio was correlated with FEV1 (%pred), (r=0.490, p=0.001). The overall number of alveolar macrophages was significantly higher in COPD patients compared to non-COPD smokers (p=0.001). The percentage of SP-A positive alveolar macrophages was higher in COPD patients versus non-COPD smokers (p=0.002) and this correlated to airway obstruction (FEV1% pred), (r=0.281, p=0.04) 6 In conclusion, our results indicate that alternate SP-A expression could be another link to COPD pathogenesis and highlights the need for further studies on surfactant markers in COPD

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vlachaki, Eleni
  • Βλαχάκη, Ελένη

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24854

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vlachaki, Eleni; Βλαχάκη, Ελένη. Ιστοειδική έκφραση ανοσορυθμιστικών μεσολαβητών σε πνευμονικό ιστό ασθενών με Χ.Α.Π. και συσχέτιση με γενετική αστάθεια στο Μικροδορυφορικό DNA. University of Crete (UOC), 2009. http://hdl.handle.net/10442/hedi/24854